Pfizer expects $15 billion in COVID-19 vaccine sales

Pfizer expects $15 billion in COVID-19 vaccine sales

Pfizer expects to generate about $15 billion in sales this year from the COVID-19 vaccine that it developed with German partner BioNTech.

Share:

Comments

Comentarios de Facebook